Reply to: "Rethinking risk indices in pediatric MASLD".
作者信息
Song Kyungchul, Kwon Yu-Jin
机构信息
Department of Pediatrics, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea.
Department of Family Medicine, Yonsei University College of Medicine, Yongin Severance Hospital, Yongin-si, Republic of Korea.
出版信息
JHEP Rep. 2025 Jul 31;7(10):101533. doi: 10.1016/j.jhepr.2025.101533. eCollection 2025 Oct.
Abstract
摘要
相似文献
1
Reply to: "Rethinking risk indices in pediatric MASLD".回复：“重新思考儿童非酒精性脂肪性肝病的风险指数”。
JHEP Rep. 2025 Jul 31;7(10):101533. doi: 10.1016/j.jhepr.2025.101533. eCollection 2025 Oct.
2
Rethinking risk indices in pediatric MASLD.重新审视儿童非酒精性脂肪性肝病的风险指数。
JHEP Rep. 2025 Jul 12;7(10):101522. doi: 10.1016/j.jhepr.2025.101522. eCollection 2025 Oct.
3
Call to action - pediatric MASLD requires immediate attention to curb health crisis.行动呼吁——儿童非酒精性脂肪性肝病相关代谢功能障碍需要立即引起关注，以遏制健康危机。
Hepatology. 2025 Jun 23. doi: 10.1097/HEP.0000000000001440.
4
Associations Between Shift Work, Sociodemographic and Lifestyle Characteristics, Body Measurements, and MASLD.轮班工作、社会人口学和生活方式特征、身体测量指标与代谢功能障碍相关脂肪性肝病之间的关联。
Life (Basel). 2025 Jun 16;15(6):961. doi: 10.3390/life15060961.
5
Optimal Cutoffs of Fatty Liver Index and Hepatic Steatosis Index in Diagnosing Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease.用于诊断儿童代谢功能障碍相关脂肪性肝病的脂肪肝指数和肝脂肪变性指数的最佳临界值
Clin Gastroenterol Hepatol. 2025 Jun 27. doi: 10.1016/j.cgh.2025.06.011.
6
Beyond BMI: revealing metabolic risk in lean MASLD.超越体重指数：揭示瘦型代谢相关脂肪性肝病的代谢风险。
Arch Clin Cases. 2025 Aug 4;12(3):110-118. doi: 10.22551/2025.48.1203.10322. eCollection 2025.
7
Metabolic dysfunction-associated steatotic liver disease is associated with the risk of severe liver fibrosis in pediatric population.代谢功能障碍相关脂肪性肝病与儿童人群严重肝纤维化风险相关。
Gastroenterol Rep (Oxf). 2025 Jun 16;13:goaf056. doi: 10.1093/gastro/goaf056. eCollection 2025.
8
Breaking boundaries: Unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada.突破界限：解析印度和加拿大儿童中与代谢功能障碍相关的脂肪性肝病
Can Liver J. 2024 Feb 26;7(3):327-337. doi: 10.3138/canlivj-2023-0023. eCollection 2024 Aug.
9
Glucagon-like Peptide-1 Receptor Agonists-A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD).胰高血糖素样肽-1受体激动剂——治疗儿童代谢功能障碍相关脂肪性肝病（MASLD）的一种潜在新药。
Children (Basel). 2024 Feb 23;11(3):275. doi: 10.3390/children11030275.
10
Ability of triglyceride-glucose indices to predict metabolic dysfunction associated with steatotic liver disease in pediatric obesity.甘油三酯-葡萄糖指数预测儿童肥胖中与脂肪性肝病相关代谢功能障碍的能力。
J Pediatr Gastroenterol Nutr. 2025 Aug 22. doi: 10.1002/jpn3.70201.
本文引用的文献
1
Identification of pediatric MASLD using insulin resistance indices.使用胰岛素抵抗指数识别儿童代谢相关脂肪性肝病
JHEP Rep. 2025 Apr 3;7(7):101419. doi: 10.1016/j.jhepr.2025.101419. eCollection 2025 Jul.
2
Nonalcoholic fatty liver disease and insulin resistance in children.儿童非酒精性脂肪性肝病与胰岛素抵抗
Clin Exp Pediatr. 2023 Dec;66(12):512-519. doi: 10.3345/cep.2022.01312. Epub 2023 Jan 9.
3
Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy.磁共振成像-质子密度脂肪分数与瞬时弹性成像-受控衰减参数在诊断儿童和青少年非酒精性脂肪性肝病中的比较：诊断准确性的Meta分析
Front Pediatr. 2022 Jan 11;9:784221. doi: 10.3389/fped.2021.784221. eCollection 2021.
4
Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017-2018 National Health and Nutrition Examination Survey.2017 - 2018年全国健康与营养检查调查中通过瞬时弹性成像检测的青少年肝脂肪变性和肝纤维化患病率
Clin Gastroenterol Hepatol. 2021 Feb;19(2):384-390.e1. doi: 10.1016/j.cgh.2020.06.048. Epub 2020 Jul 3.
5
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义：国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
6
Alcohol Initiation and Progression to Use, Heavy Episodic Use, and Alcohol Use Disorder Among Young Adolescents Ages 12-14 Living in U.S. Households.居住在美国家庭中的12至14岁青少年开始饮酒并发展为饮酒、大量饮酒及酒精使用障碍的情况。
J Stud Alcohol Drugs. 2017 Nov;78(6):853-860. doi: 10.15288/jsad.2017.78.853.
Zotero 插件